Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatoblastoma today. Our experience]

V Martínez Ibáñez1, A Marqués Gubern, M de Diego

  • 1Departamento de Cirugía Pediátrica, Hospital Materno-Infantil Vall d'Hebrón, Universidad Autónoma Barcelona.

Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica
|January 1, 1996
PubMed
Summary

Improved hepatoblastoma (HB) treatment, combining preoperative chemotherapy and surgery, has dramatically increased survival rates from 0% to 100% in pediatric patients. This evolution in pediatric oncology care highlights the success of modern therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miRNA-7 and miRNA-324-5p regulate alpha9-Integrin expression and exert anti-oncogenic effects in rhabdomyosarcoma.

Cancer letters·2020
Same author

Early cardiac remodeling in aortic coarctation: insights from fetal and neonatal functional and structural assessment.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2020
Same author

Structural and molecular study of the supraspinatus muscle of modern humans (Homo sapiens) and common chimpanzees (Pan troglodytes).

American journal of physical anthropology·2018
Same author

Ligand-dependent Hedgehog pathway activation in Rhabdomyosarcoma: the oncogenic role of the ligands.

British journal of cancer·2017
Same author

Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2017
Same author

BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways.

Oncogene·2016

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Chemotherapy

Context:

  • Hepatoblastoma (HB) treatment has evolved significantly over decades.
  • Early HB therapy involved chemotherapy alone, with poor outcomes.
  • Subsequent approaches incorporated delayed surgery and later, protocolized preoperative chemotherapy with accurate surgical removal.

Purpose:

  • To present the therapeutic evolution of hepatoblastoma at a single center.
  • To evaluate the impact of changing treatment protocols on patient survival.
  • To underscore the importance of preoperative chemotherapy and surgical technique in HB management.

Summary:

  • A retrospective analysis of 44 hepatoblastoma patients treated from 1966 onwards was conducted.
  • Group I (chemotherapy alone) had 0% survival.

Related Experiment Videos

  • Group II (preoperative chemotherapy and delayed surgery) had 15% survival.
  • Group III (protocolized preoperative chemotherapy and accurate surgery - SIOPEL-1) achieved 100% survival.

    • Impact:

    • The study demonstrates a paradigm shift in hepatoblastoma treatment outcomes.
    • Preoperative chemotherapy facilitates tumor shrinkage, improving surgical resectability.
    • Accurate surgical techniques enable the safe removal of large tumors, crucial for cure.
    • Adoption of these combined therapeutic pillars is essential for improving pediatric hepatoblastoma survival rates.